Clinical aspects of the arachidonic acid--thromboxane pathway.
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000378:metabolism / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000378:metabolism; D011464:Epoprostenol / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors; D017482:Receptors, Thromboxane; D013927:Thrombosis / Q000188:drug therapy / Q000378:metabolism*; D013928:Thromboxane A2 / Q000378:metabolism; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D001095:Arachidonic Acids; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D016718:Arachidonic Acid; D013928:Thromboxane A2; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; D001241:Aspirin